Sfoglia per Autore
GBPM: applicazione al docking molecolare
2008-01-01 Alcaro, S; Costa, G; Artese, A; Ortuso, F
Computational study on DNA G-quadruplex binding compounds
2009-01-01 Alcaro, S; Costa, G; Parrotta, L; Artese, A; Ortuso, F
Computational approaches for discovery and optimization of G-quadruplex binders
2009-01-01 Costa, G; Distinto, S; Ortuso, F; Parrotta, L; Artese, A; Alcaro, S
Docking comparativo per lo sviluppo di ligandi per il DNA G-Quadruplex
2009-01-01 Alcaro, S; Artese, A; Costa, G; Distinto, S; Parrotta, L; Ortuso, F
Docking comparativo nello sviluppo di ligandi per il DNA G-quadruplex
2009-01-01 Alcaro, S; Artese, A; Costa, G; Distinto, S; Ortuso, F; Parrotta, L
Comparison of Computational Methods in Docking Experiments of G-Quadruplex Binders
2009-01-01 Alcaro, S; Costa, G; Parrotta, L; Artese, A; Ortuso, F
Rational drug design of DNA G-quadruplex binders using in silico approaches
2010-01-01 Alcaro, S; Artese, A; Costa, G; Distinto, S; Ortuso, F; Parrotta, L
Molecular modelling of chemically diverse scaffolds of cyclooxygenase inhibitors
2010-01-01 Alcaro, S; Artese, A; Costa, G; Distinto, S; Ortuso, F; Parrotta, L
MOLECULAR MODELING OF CHEMICALLY DIVERSE SCAFFOLD OF CICLOOXYGENASE INHIBITORS
2010-01-01 Alcaro, S; Artese, A; Costa, G; Distinto, S; Ortuso, F; Parrotta, L
Molecular Recognition Of Dna G-Quadruplex Ligands By Different Docking Methods
2010-01-01 Alcaro, S; Artese, A; Costa, G; Distinto, S; Ortuso, F; Parrotta, L
Technical details about rational drug design of new DNA G-quadruplex ligands
2010-01-01 Alcaro, S; Costa, G; Distinto, S; Ortuso, F; Parrotta, L; Artese, A
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase
2010-01-01 Maccioni, E; Alcaro, S; Orallo, F; Cardia, M. C.; Distinto, S; Costa, G; Yanez, M; Sanna, M. L.; Vigo, S; Meleddu, R; Secci, D
Simple choline esters as potential anti-Alzheimer agents
2010-01-01 Arcone, R; Costa, G; DE VITA, D; Iannone, M; Ortuso, F; Pasceri, R; Rotiroti, D; Scipione, L; Procopio, A; Alcaro, S
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir containing regimens
2010-01-01 Svicher, V; Alteri, C; Artese, A; Forbici, A; Santoro, F; Schols, M. M.; Van, Laethem; Costa, S; Tommasi, G; Zaccarelli, C; Narciso, M; Antinori, P; CECCHERINI-SILBERSTEIN, A; Balzarini, F; Perno, J; Alcaro, S
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral treated HIV-1 infected patients, all naïve to integrase inhibitors
2010-01-01 CECCHERINI-SILBERSTEIN, F; Malet, I; Fabeni, L; Dimonte, S; Svicher, V; Darrigo, R; Artese, A; Costa, A; Bono, G; Darminio, Monforte; Katlama, A; Calvez, C; Antinori, V; Marcelin, A; Perno, A. G.; Alcaro, S
Metodi computazionali e nutraceutica
2010-01-01 Costa, G; Distinto, S; Ortuso, F; Parrotta, L; Alcaro, S; Artese, A
Molecular docking, synthesis and biological evaluation of indomethacin analogs as novel cyclooxygenase inhibitors.
2011-01-01 Alcaro, S; Artese, A; Costa, G; Distinto, S; Moraca, F; Ortuso, F; Parrotta, L
Identification of new G-quadruplex binders by combined virtual screening approaches.
2011-01-01 Alcaro, S; Artese, A; Costa, G; Distinto, S; Moraca, F; Ortuso, F; Parrotta, L
Structure-based pharmacophore modeling of DNA G-Quadruplex ligand-complexes.
2011-01-01 Alcaro, S; Artese, A; Costa, G; Distinto, S; Moraca, F; Ortuso, F; Parrotta, L
Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase
2011-01-01 Alcaro, S; Alteri, C; Ceccherini-Silberstein, F; Costa, G; Parrotta, L; Perno, Cf; Svicher, V; Artese, A; Ortuso, F
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
GBPM: applicazione al docking molecolare | 1-gen-2008 | Alcaro, S; Costa, G; Artese, A; Ortuso, F | |
Computational study on DNA G-quadruplex binding compounds | 1-gen-2009 | Alcaro, S; Costa, G; Parrotta, L; Artese, A; Ortuso, F | |
Computational approaches for discovery and optimization of G-quadruplex binders | 1-gen-2009 | Costa, G; Distinto, S; Ortuso, F; Parrotta, L; Artese, A; Alcaro, S | |
Docking comparativo per lo sviluppo di ligandi per il DNA G-Quadruplex | 1-gen-2009 | Alcaro, S; Artese, A; Costa, G; Distinto, S; Parrotta, L; Ortuso, F | |
Docking comparativo nello sviluppo di ligandi per il DNA G-quadruplex | 1-gen-2009 | Alcaro, S; Artese, A; Costa, G; Distinto, S; Ortuso, F; Parrotta, L | |
Comparison of Computational Methods in Docking Experiments of G-Quadruplex Binders | 1-gen-2009 | Alcaro, S; Costa, G; Parrotta, L; Artese, A; Ortuso, F | |
Rational drug design of DNA G-quadruplex binders using in silico approaches | 1-gen-2010 | Alcaro, S; Artese, A; Costa, G; Distinto, S; Ortuso, F; Parrotta, L | |
Molecular modelling of chemically diverse scaffolds of cyclooxygenase inhibitors | 1-gen-2010 | Alcaro, S; Artese, A; Costa, G; Distinto, S; Ortuso, F; Parrotta, L | |
MOLECULAR MODELING OF CHEMICALLY DIVERSE SCAFFOLD OF CICLOOXYGENASE INHIBITORS | 1-gen-2010 | Alcaro, S; Artese, A; Costa, G; Distinto, S; Ortuso, F; Parrotta, L | |
Molecular Recognition Of Dna G-Quadruplex Ligands By Different Docking Methods | 1-gen-2010 | Alcaro, S; Artese, A; Costa, G; Distinto, S; Ortuso, F; Parrotta, L | |
Technical details about rational drug design of new DNA G-quadruplex ligands | 1-gen-2010 | Alcaro, S; Costa, G; Distinto, S; Ortuso, F; Parrotta, L; Artese, A | |
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase | 1-gen-2010 | Maccioni, E; Alcaro, S; Orallo, F; Cardia, M. C.; Distinto, S; Costa, G; Yanez, M; Sanna, M. L.; Vigo, S; Meleddu, R; Secci, D | |
Simple choline esters as potential anti-Alzheimer agents | 1-gen-2010 | Arcone, R; Costa, G; DE VITA, D; Iannone, M; Ortuso, F; Pasceri, R; Rotiroti, D; Scipione, L; Procopio, A; Alcaro, S | |
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir containing regimens | 1-gen-2010 | Svicher, V; Alteri, C; Artese, A; Forbici, A; Santoro, F; Schols, M. M.; Van, Laethem; Costa, S; Tommasi, G; Zaccarelli, C; Narciso, M; Antinori, P; CECCHERINI-SILBERSTEIN, A; Balzarini, F; Perno, J; Alcaro, S | |
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral treated HIV-1 infected patients, all naïve to integrase inhibitors | 1-gen-2010 | CECCHERINI-SILBERSTEIN, F; Malet, I; Fabeni, L; Dimonte, S; Svicher, V; Darrigo, R; Artese, A; Costa, A; Bono, G; Darminio, Monforte; Katlama, A; Calvez, C; Antinori, V; Marcelin, A; Perno, A. G.; Alcaro, S | |
Metodi computazionali e nutraceutica | 1-gen-2010 | Costa, G; Distinto, S; Ortuso, F; Parrotta, L; Alcaro, S; Artese, A | |
Molecular docking, synthesis and biological evaluation of indomethacin analogs as novel cyclooxygenase inhibitors. | 1-gen-2011 | Alcaro, S; Artese, A; Costa, G; Distinto, S; Moraca, F; Ortuso, F; Parrotta, L | |
Identification of new G-quadruplex binders by combined virtual screening approaches. | 1-gen-2011 | Alcaro, S; Artese, A; Costa, G; Distinto, S; Moraca, F; Ortuso, F; Parrotta, L | |
Structure-based pharmacophore modeling of DNA G-Quadruplex ligand-complexes. | 1-gen-2011 | Alcaro, S; Artese, A; Costa, G; Distinto, S; Moraca, F; Ortuso, F; Parrotta, L | |
Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase | 1-gen-2011 | Alcaro, S; Alteri, C; Ceccherini-Silberstein, F; Costa, G; Parrotta, L; Perno, Cf; Svicher, V; Artese, A; Ortuso, F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile